Karin Jandeleit‐Dahm

14.4k citations
157 papers · 10.8k indexed · 2 hit papers · h-index 57
Topics
Advanced Glycation End Products research (48 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (33 papers)Chronic Kidney Disease and Diabetes (30 papers)

In The Last Decade

Karin Jandeleit‐Dahm

153 papers receiving 10.6k citations

Hit Papers

Diabetic kidney disease201520262018202220152016250500750

Peers

Karin Jandeleit‐Dahm
Comparison fields: 5 of 137
  • Molecular Biology 3.7k
  • Endocrinology, Diabetes and Metabolism 2.4k
  • Clinical Biochemistry 2.2k
  • Nephrology 1.9k
  • Immunology 1.9k
Replace Daisuke Koya with:
Daisuke Koya Japan
Masakazu Haneda Japan
Frank C. Brosius United States
Hanna E. Abboud United States
Toshio Miyata Japan
Fuad N. Ziyadeh United States
Michael Brownlee United States
Seiya Okuda Japan
Lin Sun China
Hans‐Peter Hammes Germany
Karin Jandeleit‐Dahm relative to Daisuke Koya Japan Daisuke Koya's profile →
Citations per field
00.5×1.7×
Daisuke Koya · 1×
Citations per year

Countries citing papers authored by Karin Jandeleit‐Dahm

Since Specialization
Citations

This map shows the geographic impact of Karin Jandeleit‐Dahm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Jandeleit‐Dahm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Jandeleit‐Dahm more than expected).

Fields of papers citing papers by Karin Jandeleit‐Dahm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Jandeleit‐Dahm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Jandeleit‐Dahm. The network helps show where Karin Jandeleit‐Dahm may publish in the future.

Co-authorship network of co-authors of Karin Jandeleit‐Dahm

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Jandeleit‐Dahm. A scholar is included among the top collaborators of Karin Jandeleit‐Dahm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Jandeleit‐Dahm. Karin Jandeleit‐Dahm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 0
3 3
4 31
5 7
6 9
7 13
8 29
9 26
10 67
11 121
12
Diabetes and Kidney Disease: Role of Oxidative Stressbreakdown →
518
13 105
14 34
15 15
16 28
17 37
18 6
19 98
20 17

About Karin Jandeleit‐Dahm

Karin Jandeleit‐Dahm is a scholar working on Clinical Biochemistry, Nephrology and Immunology, having authored 157 papers that have together received 10.8k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (48 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (33 papers) and Chronic Kidney Disease and Diabetes (30 papers). The work is most often cited by research in Clinical Biochemistry (2.2k citations), Nephrology (1.9k citations) and Endocrinology, Diabetes and Metabolism (2.4k citations). Karin Jandeleit‐Dahm has collaborated with scholars based in Australia, Germany and United Kingdom. Frequent co-authors include Mark E. Cooper, Merlin C. Thomas, Jay C. Jha, Terri J. Allen, Stephen P. Gray, Anna C. Calkin, Anna M.D. Watson, Bryna S.M. Chow, Markus Lassila and Harald Schmidt. Their work appears in journals such as Circulation, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026